Clinical trials
Completed Phase 2 Kidney Failure, Chronic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
121 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 4 |
| 2003 | 3 |
| 2004 | 2 |
| 2005 | 8 |
| 2006 | 9 |
| 2007 | 4 |
| 2008 | 10 |
| 2009 | 6 |
| 2010 | 6 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 7 |
| 2014 | 10 |
| 2015 | 4 |
| 2016 | 7 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 4 |
| 2021 | 3 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 121 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vanderbilt University | 8 |
| Affymax | 4 |
| Amgen | 4 |
| Iperboreal Pharma Srl | 3 |
| Kyntra Bio | 3 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 3 |
| Otsuka Pharmaceutical Co., Ltd. | 3 |
| Shiraz University of Medical Sciences | 3 |
| University of Pennsylvania | 3 |
| Ardelyx | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Failure, Chronic | 121 |
| Renal Insufficiency, Chronic | 19 |
| Anemia | 14 |
| Renal Insufficiency | 8 |
| Diabetes Mellitus | 6 |
| Hyperphosphatemia | 5 |
| Kidney Diseases | 5 |
| Hyperparathyroidism, Secondary | 4 |
| Pruritus | 4 |
| Cardiovascular Diseases | 3 |
Trials
Showing 1 to 25 of 121. Each trial links to its page on Pharma Observatory.
21 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.